| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 16 |
| 1 | ADALIMUMAB | 10 |
| 2 | AGALSIDASE BETA | 9 |
| 3 | GABAPENTIN | 9 |
| 4 | ECULIZUMAB | 8 |
| 5 | FOLIC ACID | 8 |
| 6 | HYDROXYCHLOROQUINE | 8 |
| 7 | METHOTREXATE SODIUM | 8 |
| 8 | ACETAMINOPHEN | 7 |
| 9 | AVALGLUCOSIDASE ALFA-NGPT | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVALGLUCOSIDASE ALFA-NGPT | 7 | 0.0070 |
| 1 | IPTACOPAN | 2 | 0.0025 |
| 2 | ALGLUCOSIDASE ALFA | 5 | 0.0021 |
| 3 | PEGCETACOPLAN | 3 | 0.0016 |
| 4 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0011 |
| 5 | DICLOXACILLIN SODIUM | 1 | 0.0011 |
| 6 | AGALSIDASE BETA | 9 | 0.0010 |
| 7 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 8 | LARONIDASE | 3 | 0.0007 |
| 9 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 12 | 0.0035 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 9 | 0.0009 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 5 | Complement Inhibitor [EPC] | 11 | 0.0002 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Barbiturate [EPC] | 1 | 0.0001 |